New York, Sep 25th, 2019 – CRISPR/Cas9 platform, which is a major division of Creative Biogene, offering professional products and services to accelerate gene research. As a supplier that has devoted years of efforts providing comprehensive gene editing services and products, recently announced the release of its brand new knockin mouse generation service in order to boost gene editing projects, thereby, applied in the gene function study and therapeutically humanized antibodies production.
CRISPR/Cas9 platform comprises a full set of knockin mouse generation services, ranging from point mutation mice, ROSA26 knockin mice to custom knockin mice and conditional knockin mice. Knockin mouse is an important research model in which foreign genes or DNA fragments are introduced into the mouse genome and passed on to the next generation, which is widely applied in various fields, including the study of regulatory elements such as promotors to the production of therapeutically useful humanized antibodies. As the latest technology, CRISPR/Cas9 is the main method for genome-generated mouse generation.
CRISPR/Cas9 platform focuses on providing transgenic mouse models for biomedical research and drug discovery. Our service is designed to provide with one-stop solutions from experimental design strategies to successful mouse model generation. The unique expertise involves the ability to offer CRISPR-based knockin mouse at very competitive prices, usually finished within 3-4 months, and delivery of at least 2 founders or 3 F1 animals for percussion can be guaranteed.
Because of the extensive experience in the application of CRISPR/Cas9 gene editing technology and the successful knockout/knockout of specific genes in 300 mice, CRISPR/Cas9 platform is able to provide comprehensive and effective point mutations based on the genes offered, thus to maximize Cas9 efficiency, including gRNA design and synthesis, donor vector construction, PCR primers for genotyping. The following steps include the comprehensive services from strategy design to F1 mice. All of which guarantee CRISPR/Cas platform the ability to provide powerful support in the field of preclinical safety and toxicity studies, drug screening and development etc.
“With years of efforts in CRISPR/Cas gene editing models, CRISPR/Cas9 platform can provide a full range of services based on extensive experience in manipulating animal embryos and have successfully integrated CRISPR-Cas9 technology into various programs, which has been well valued by our customers.” said Marcia Brady, the marketing director of Creative Biogene, she also said that, “We have state-of-the-art laboratories that meet standard animal feeding conditions and experienced scientists. And we are capable to offer customized solutions to meet your specific requirements to protect your scientific investment.”
About CRISPR/Cas9 platform
CRISPR/Cas9 platform, as a professional division of Creative Biogene, is dedicated to supporting our clients conduct genetic research with comprehensive gene editing services and products as well as experienced in-house experts. With years of efforts, Creative Biogene CRISPR/Cas9 platform has become a world-recognized industry platform that supports millions of scientists worldwide.
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States